Cardiomedex is a niche contract research organization (CRO) dedicated to examining the cardiovascular effects of drugs candidates. The company is based on a new concept: generate preclinical and early clinical proof-of concept evidence to optimize drug development.
We bring an innovative vision to research by combining key clinical pharmacology
skills with scientific expertise in cardiovascular diseases (myocardial infarction, cardiac arrhythmia, cardiac hypertophy, heart failure, hypertension) and cardiotoxicity. We also have unique expertise in onco-cardiology and neurocardiology (autonomic dysfunction, ...).